These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2710506)

  • 21. [Involvement of the central nervous system in myotonic dystrophy--a clinical, computerized tomographic and electrophysiological studies].
    Fukui R; Tobimatsu S; Iwashita H; Kato M; Kuroiwa Y
    Rinsho Shinkeigaku; 1985 Jan; 25(1):6-11. PubMed ID: 3995849
    [No Abstract]   [Full Text] [Related]  

  • 22. Multimodality evoked potentials in myotonic dystrophy.
    Sartucci F; Marconi F; Busso E; Rossi B; Murri L
    Ital J Neurol Sci; 1989 Feb; 10(1):61-7. PubMed ID: 2925346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular findings in myotonic dystrophy.
    Raitta C; Karli P
    Ann Ophthalmol; 1982 Jul; 14(7):647-50. PubMed ID: 7125455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypotonia bulbi and gonadotropins in myotonic dystrophy].
    Küchle M; Naumann GO; Völcker HE; Sears ML
    Klin Monbl Augenheilkd; 1988 Oct; 193(4):388-92. PubMed ID: 3148784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ocular findings in patients with Steinert myotonic dystrophy].
    Markowska E; Zalewska R; Mariak Z; Wojnar M
    Przegl Lek; 2006; 63(8):662-3. PubMed ID: 17441379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
    Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
    Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foveal photopigment kinetics--abnormality: an early sign in myotonic dystrophy?
    ter Bruggen JP; van Meel GJ; Paridaens AD; Tijssen CC; van Norren D
    Br J Ophthalmol; 1992 Oct; 76(10):594-7. PubMed ID: 1420041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute and long-term ocular effects of accelerated hypertension: a clinical and electrophysiological study.
    Talks SJ; Good P; Clough CG; Beevers DG; Dodson PM
    Eye (Lond); 1996; 10 ( Pt 3)():321-7. PubMed ID: 8796156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.
    Murro V; Mucciolo DP; Passerini I; Palchetti S; Sodi A; Virgili G; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2099-2111. PubMed ID: 28752371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined use of pattern electroretinography and pattern visual evoked potentials in neuroophthalmological practice].
    Benedek K; Pálffy A; Bencsik K; Fejes I; Rajda C; Tuboly G; Liszli P
    Ideggyogy Sz; 2008 Jan; 61(1-2):33-41. PubMed ID: 18372773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced retinal responses without signs of optic nerve involvement.
    Feinsod M; Rowe H; Auerbach E
    Doc Ophthalmol; 1971 May; 29(2):201-11. PubMed ID: 5088862
    [No Abstract]   [Full Text] [Related]  

  • 33. [Maculopathy in Curschmann-Steinert myotonic dystrophy].
    Giusti C
    Recenti Prog Med; 2003 Jan; 94(1):16-8. PubMed ID: 12632995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular changes in myotonic dystrophy.
    Burian HM; Burns CA
    Am J Ophthalmol; 1967 Jan; 63(1):22-34. PubMed ID: 6017679
    [No Abstract]   [Full Text] [Related]  

  • 35. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The electroretinogram and visual evoked potentials in patients with Parkinson's disease].
    Burguera JA; Vilela C; Traba A; Ameave Y; Vallet M
    Arch Neurobiol (Madr); 1990; 53(1):1-7. PubMed ID: 2393335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual dysfunction in patients with mitochondrial myopathies. I. Electrophysiologic impairments.
    Ambrosio G; De Marco R; Loffredo L; Magli A
    Doc Ophthalmol; 1995; 89(3):211-8. PubMed ID: 7555588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.
    Rotenstreich Y; Fishman GA; Anderson RJ
    Ophthalmology; 2003 Jun; 110(6):1151-8. PubMed ID: 12799240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Male sex, erythema nodosum, and electroretinography as predictors of visual prognosis after cataract surgery in patients with Behçet disease.
    Hu K; Lei B; Kijlstra A; Li P; Zhang X; Xiao X; Li F; Xu H; Yang P
    J Cataract Refract Surg; 2012 Aug; 38(8):1382-8. PubMed ID: 22727990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.